PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21664904-4	2011	Pretreatment with levosimendan reversed the effects of ischaemia and ischaemia/reperfusion on cell viability and enhanced phosphorylation of Akt, p38-mitogen activated protein kinase (MAPK) and extracellular signal-regulated kinases 1/2 (ERK1/2).	Simendan	18-30	mitogen-activated protein kinase 3	Homo sapiens	238-244	
21664904-6	2011	Levosimendan stimulated the phosphorylation of Akt, ERK1/2 and p38-MAPK with different kinetics and the activation of these pathways was dependent on the opening of the mitochondrial K(ATP) channels and the production of oxygen free radicals.	Simendan	0-12	mitogen-activated protein kinase 3	Homo sapiens	52-58	
21664904-7	2011	The levosimendan-induced phosphorylation of ERK1/2 and Akt was reduced by inhibitors of epidermal growth factor receptor and Src.	Simendan	4-16	mitogen-activated protein kinase 3	Homo sapiens	44-50	
21237146-13	2011	The significant increase in the activity of prosurvival mediators ERK 1/2 and P38 following hypoxia indicates a potential mechanism of action for levosimendan-induced cardioprotection.	Simendan	146-158	mitogen-activated protein kinase 3	Homo sapiens	66-73